ATE87827T1 - Anti-hiv-wirkung von bu-3608. - Google Patents

Anti-hiv-wirkung von bu-3608.

Info

Publication number
ATE87827T1
ATE87827T1 AT89112126T AT89112126T ATE87827T1 AT E87827 T1 ATE87827 T1 AT E87827T1 AT 89112126 T AT89112126 T AT 89112126T AT 89112126 T AT89112126 T AT 89112126T AT E87827 T1 ATE87827 T1 AT E87827T1
Authority
AT
Austria
Prior art keywords
susceptible
hiv
aids
infection
preventing
Prior art date
Application number
AT89112126T
Other languages
English (en)
Inventor
Toshikazu Oki
Naoki Yamamoto
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE87827T1 publication Critical patent/ATE87827T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89112126T 1988-07-01 1989-07-03 Anti-hiv-wirkung von bu-3608. ATE87827T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21422688A 1988-07-01 1988-07-01
EP89112126A EP0351625B1 (de) 1988-07-01 1989-07-03 Anti-HIV-Wirkung von BU-3608

Publications (1)

Publication Number Publication Date
ATE87827T1 true ATE87827T1 (de) 1993-04-15

Family

ID=22798273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89112126T ATE87827T1 (de) 1988-07-01 1989-07-03 Anti-hiv-wirkung von bu-3608.

Country Status (12)

Country Link
EP (1) EP0351625B1 (de)
JP (1) JP2802336B2 (de)
KR (1) KR0131323B1 (de)
AT (1) ATE87827T1 (de)
CA (1) CA1335078C (de)
CY (1) CY1847A (de)
DE (1) DE68905875T2 (de)
ES (1) ES2054935T3 (de)
GR (1) GR3007580T3 (de)
HK (1) HK110095A (de)
IL (1) IL90783A (de)
ZA (1) ZA894984B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics

Also Published As

Publication number Publication date
KR0131323B1 (ko) 1998-04-17
DE68905875T2 (de) 1993-07-15
DE68905875D1 (de) 1993-05-13
JP2802336B2 (ja) 1998-09-24
JPH0248530A (ja) 1990-02-19
ZA894984B (en) 1990-03-28
EP0351625A1 (de) 1990-01-24
IL90783A (en) 1994-01-25
CY1847A (en) 1996-03-08
EP0351625B1 (de) 1993-04-07
IL90783A0 (en) 1990-01-18
HK110095A (en) 1995-07-14
KR900001374A (ko) 1990-02-27
CA1335078C (en) 1995-04-04
ES2054935T3 (es) 1994-08-16
GR3007580T3 (de) 1993-08-31

Similar Documents

Publication Publication Date Title
DE3751682D1 (de) Infektiöses System zur Arzneimittelabgabe
DK524788A (da) Anvendelse af morphin-antagonister til fremstilling af laegemidler med immunomodulerende og antiviral effekt, isaer til behandling af erhvervede immundefekt-tilstande
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
DE3780016D1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
AU8448091A (en) Novel polypeptide and anti-hiv drug prepared therefrom
DE59003763D1 (de) Gemischte, teilneutralisierte Salze von niederen Alkyl-Vinyl-Ether Maleinsäure Copolymeren und damit hergestellte Zahnprothesehaftmittel.
ES2081286T3 (es) Nucleosidos de pirimidina antivirus del sida.
EP0323157A3 (de) Antivirale Verbindungen und Methoden
ATE87827T1 (de) Anti-hiv-wirkung von bu-3608.
FI901879A0 (fi) Foerfarande foer producering av naturligt hiv-gp160.
EP0255242A3 (de) Oncornavirusimpfstoffe
FI881123A7 (fi) Human Immunodeficiency Viruksen (HIV) inaktivoiminen proteiinipitoisissa liuoksissa fenolilla.
EP0316592A3 (de) 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
DE59100308D1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
UA7930A1 (uk) 2-(2,7-діацетоксіфлуорениліден-9-гідразоно)-5-фурфурилідентіазолідон-4, що виявляє противірусну дію відносно віруса венесуельського енцефаліту коней та віруса грипа типу а та а-2
UA6149A1 (uk) 2-(2'7'-діацетоксіфлуореніліден-9'-гідразоно)-5-(п-нітробензіліден)-тіазолідон-4,що виявляє противірусну дію щодо віруса грипу а та а-2, а також віруса осповакцини
DE68929084D1 (de) Arzneimittel zur Verhinderung einer Infektion mit dem für AIDS verantwortlichen Virus
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека
LV10497A (lv) Panemiens vakcinas iegusanai kas satur no HIV-1 virusa apvalka gena atvasinatus polipeptidus
UA6146A1 (uk) 1,1-біс-[2-(2,7-діацетоксифлуорениліден-9-гідразоно)тиазолідон-4-іл-5]-о-нітрофенилметан, що виявляє антивірусну дію відносно рнк- та днк- вмістних вірусів

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee